Health
New drug regimen is safe and effective in children with cystic fibrosis – News-Medical.Net
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, found that a regimen of three…
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
For children in this age group who have…
-
Noosa News14 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News12 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News22 hours agoCountdown on for Noosa Eat & Drink Festival 2025